Cytek Biosciences Inc (CTKB)
5.76
+0.13
(+2.31%)
USD |
NASDAQ |
Apr 26, 16:00
5.76
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Debt to Equity Ratio: 0.0056 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0056 |
| September 30, 2023 | 0.0055 |
| June 30, 2023 | 0.0057 |
| March 31, 2023 | 0.0064 |
| December 31, 2022 | 0.0067 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.1839 |
| December 31, 2020 | -0.1729 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1839
Minimum
Mar 2021
0.0067
Maximum
Dec 2022
-0.0251
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Ainos Inc | 0.2439 |
| OpGen Inc | 3.437 |
| Zomedica Corp | 0.00 |
| LENSAR Inc | 0.00 |
| Eargo Inc (DELISTED) | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 494.46M |
| Total Liabilities (Quarterly) | 101.39M |
| Shareholders Equity (Quarterly) | 393.06M |
| Current Ratio | 6.973 |
| Net Debt Paydown Yield | -0.04% |